Neuroprotection in Glaucoma
Author Information
Author(s): Vasudevan Sushil K, Gupta Viney, Crowston Jonathan G
Primary Institution: Centre for Eye Research Australia, University of Melbourne
Hypothesis
Neuroprotection should be beneficial irrespective of the pathophysiology of glaucoma.
Conclusion
Neuroprotection has promise for preventing retinal ganglion cell death in glaucoma, independent of intraocular pressure.
Supporting Evidence
- Glaucoma is a neurodegenerative disease characterized by loss of retinal ganglion cells.
- Lowering intraocular pressure does not prevent progression in all patients.
- Neuroprotection aims to protect neurons from degeneration and apoptosis.
Takeaway
Glaucoma is a disease that damages the eye's nerve cells, and protecting these cells can help prevent vision loss, even if the pressure in the eye is normal.
Methodology
This review article synthesizes current understanding of glaucoma's pathophysiology and explores pharmacological approaches for neuroprotection.
Limitations
Many studies on neuroprotective agents have had low success rates in transitioning from laboratory to human trials.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website